Merkel cell carcinoma (MCC) is a rare, highly aggressive, neuroendocrine cutaneous tumor.
The incidence of MCC is growing worldwide, and the disease-related mortality is about three …

Purpose: Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer, which
can be effectively controlled by immunotherapy with PD-1/PD-L1 checkpoint inhibitors …

Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine (NE) carcinoma
arising from integration of Merkel cell polyomavirus (MCPyV) DNA into a host cell or from …

Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed
malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small …

Merkel cell carcinoma (MCC) is a rare and extremely aggressive neuroendocrine carcinoma
of the skin, with increasing incidence worldwide. This review intends to propose a …

Relatively little is known about the epidemiology of Merkel cell carcinoma (MCC) with regard
to international trends in incidence, specifically relating to differences by age, sex, and …

Recent advances in treating cutaneous melanoma have resulted in impressive patient
survival gains. Refinement of disease staging and accurate patient risk classification have …

Merkel cell carcinoma (MCC) is an aggressive skin cancer for which Merkel cell
polyomavirus integration and expression of viral oncogenes small T and Large T have been …

Merkel cell carcinoma (MCC) is a neuroendocrine tumor either induced by integration of the
Merkel cell polyomavirus into the cell genome or by accumulation of UV-light-associated …

Merkel cell carcinoma (MCC) is an uncommon primary cutaneous neuroendocrine
carcinoma associated with an adverse prognosis. In recent years, our understanding of …